Liquid Biopsy Market Estimated to Experience a Hike in Growth by 2035 Aubignosc

This report presents a detailed, data-driven analysis of the global Liquid Biopsy MarketSize, Share & Growth Trend Analysis Report (2026 - 2035) size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.

I recently came across a report by Roots Analysis that really put things into perspective. According to them, The liquid biopsy market size is valued at USD 7.0 billion in 2025, is project to reach USD 8.1 billion in 2026 and USD 29.8 billion by 2035, representing a higher CAGR of 15.6% during the forecast period 2026 to 2035.

Market Segmentation

- Historical Trend: Since 2019
- Forecast Period: Till 2035
- Market Size 2026: $ 8.1 Billion
- Market Size 2035: $ 29.8 Billion
- CAGR (Till 2035): 15.6%
- Application
                • Early Cancer Diagnosis
                • Patient Monitoring
                • Recurrence Monitoring
- Type of Target Disease Indication
                • Bladder Cancer
                • Breast Cancer
                • Colorectal Cancer
                • Gastric Cancer
                • Lung Cancer
                • Prostate cancer
                • Others
- Type of Circulating Biomarker
                • Cell Free DNA
                • Cell Free RNA
                • Circulating Tumor DNA
                • Extracellular Vesicles
                • Other Circulating Biomarkers
- Type of Sample
                • Blood / Plasma
                • Other Samples
- End User
                • Hospitals
                • Research Institutes
                • Others
- Key Geographical Regions
                • North America
                • Europe
                • Asia-Pacific
                • Rest of the World
- Key Players
                • Amoy Diagnostics
                • ArcherDX
                • Biocartis
                • Cell Search
                • CellMax Life
                • Datar Cancer Genetics
                • DiaCarta, EONE-DIAGNOMICS
                • Exosome Diagnostics
                • GeneCast Biotechnology
                • Integrated DNA Technologies
                • Lucence
                • MDNA Life Sciences
                • Miltenyi Biotec
                • NeoGenomics
                • ONCODE Scientific
                • OncoDNA
                • QIAGEN
                • PANAGENE
                • Personal Genome Diagnostics
                • Predicin
                • ScreenCell
                • Tecan
                • Thermo Fisher Scientific
- Customization Scope: 15% customization available
- PowerPoint Presentation(Complimentary): Available
- Excel Data Packs(Complimentary)
                • Market Landscape Analysis
                • Partnerships and Collaborations
                • Funding and Investment Analysis
                • Product Competitiveness Analysis
                • Big ****** Initiatives Analysis
                • Key Acquisition Targets Analysis
                • Market Forecast and Opportunity Analysis
Read More: https://shorturl.at/d7asb

Key Geographies

• North America


• Europe


• Asia-Pacific


• Middle East and North Africa


• Latin America

Each segment is analyzed by volume, value, and growth patterns, offering a comparative understanding of usage trends and market opportunities.

Share